These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 38086310)
61. Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors. Zhu C; Ding J; Wang S; Qiu Q; Ji Y; Wang L Thorac Cancer; 2021 Dec; 12(23):3110-3120. PubMed ID: 34647417 [TBL] [Abstract][Full Text] [Related]
62. 4D radiomics: impact of 4D-CBCT image quality on radiomic analysis. Zhang Z; Huang M; Jiang Z; Chang Y; Torok J; Yin FF; Ren L Phys Med Biol; 2021 Feb; 66(4):045023. PubMed ID: 33361574 [TBL] [Abstract][Full Text] [Related]
63. A Novel Nomogram Model Based on Cone-Beam CT Radiomics Analysis Technology for Predicting Radiation Pneumonitis in Esophageal Cancer Patients Undergoing Radiotherapy. Du F; Tang N; Cui Y; Wang W; Zhang Y; Li Z; Li J Front Oncol; 2020; 10():596013. PubMed ID: 33392091 [TBL] [Abstract][Full Text] [Related]
64. Impact of radiogenomics in esophageal cancer on clinical outcomes: A pilot study. Brancato V; Garbino N; Mannelli L; Aiello M; Salvatore M; Franzese M; Cavaliere C World J Gastroenterol; 2021 Sep; 27(36):6110-6127. PubMed ID: 34629823 [TBL] [Abstract][Full Text] [Related]
65. Using clinical and radiomic feature-based machine learning models to predict pathological complete response in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiation. Wang J; Zhu X; Zeng J; Liu C; Shen W; Sun X; Lin Q; Fang J; Chen Q; Ji Y Eur Radiol; 2023 Dec; 33(12):8554-8563. PubMed ID: 37439939 [TBL] [Abstract][Full Text] [Related]
66. Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signatures. Cui Y; Li Z; Xiang M; Han D; Yin Y; Ma C Radiat Oncol; 2022 Dec; 17(1):212. PubMed ID: 36575480 [TBL] [Abstract][Full Text] [Related]
67. Radiomic-Based Pathological Response Prediction from Primary Tumors and Lymph Nodes in NSCLC. Coroller TP; Agrawal V; Huynh E; Narayan V; Lee SW; Mak RH; Aerts HJWL J Thorac Oncol; 2017 Mar; 12(3):467-476. PubMed ID: 27903462 [TBL] [Abstract][Full Text] [Related]
68. Predicting Lymph Node Metastasis Using Computed Tomography Radiomics Analysis in Patients With Resectable Esophageal Squamous Cell Carcinoma. Zhao B; Zhu HT; Li XT; Shi YJ; Cao K; Sun YS J Comput Assist Tomogr; 2021 Mar-Apr 01; 45(2):323-329. PubMed ID: 33512851 [TBL] [Abstract][Full Text] [Related]
69. Individualized treatment decision model for inoperable elderly esophageal squamous cell carcinoma based on multi-modal data fusion. Huang Y; Huang X; Wang A; Chen Q; Chen G; Ye J; Wang Y; Qin Z; Xu K BMC Med Inform Decis Mak; 2023 Oct; 23(1):237. PubMed ID: 37872517 [TBL] [Abstract][Full Text] [Related]
70. Combined modalities of magnetic resonance imaging, endoscopy and computed tomography in the evaluation of tumor responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma. Qiu B; Wang D; Yang H; Xie W; Liang Y; Cai P; Chen Z; Liu M; Fu J; Xie C; Liu H Radiother Oncol; 2016 Nov; 121(2):239-245. PubMed ID: 27793445 [TBL] [Abstract][Full Text] [Related]
71. Prognostic impact of eosinophils in peripheral blood and tumor site in patients with esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy. Yang X; Wang L; Du H; Lin B; Yi J; Wen X; Geng L; Du X Medicine (Baltimore); 2021 Jan; 100(3):e24328. PubMed ID: 33546064 [TBL] [Abstract][Full Text] [Related]
72. Statin Use During Concurrent Chemoradiotherapy With Improved Survival Outcomes in Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Nationwide Cohort Study. Chen WM; Yu YH; Chen M; Shia BC; Wu SY J Thorac Oncol; 2023 Aug; 18(8):1082-1093. PubMed ID: 37085031 [TBL] [Abstract][Full Text] [Related]
73. Improved Prognosis of Treatment Failure in Cervical Cancer with Nontumor PET/CT Radiomics. Yusufaly TI; Zou J; Nelson TJ; Williamson CW; Simon A; Singhal M; Liu H; Wong H; Saenz CC; Mayadev J; McHale MT; Yashar CM; Eskander R; Sharabi A; Hoh CK; Obrzut S; Mell LK J Nucl Med; 2022 Jul; 63(7):1087-1093. PubMed ID: 34711618 [TBL] [Abstract][Full Text] [Related]
74. Development and Validation of a Nomogram for Predicting Overall Survival to Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma. Wang C; Cheng X; Jin L; Ren R; Wang S; Zheng A; Hao A; Zhou F; Zhang Y Biomed Res Int; 2022; 2022():6455555. PubMed ID: 35872847 [TBL] [Abstract][Full Text] [Related]
75. Concurrent chemoradiotherapy combined with enteral nutrition support: a radical treatment strategy for esophageal squamous cell carcinoma patients with malignant fistulae. Ma L; Luo GY; Ren YF; Qiu B; Yang H; Xie CX; Liu SR; Liu SL; Chen ZL; Li Q; Fu JH; Liu MZ; Hu YH; Ye WF; Liu H Chin J Cancer; 2017 Jan; 36(1):8. PubMed ID: 28077159 [TBL] [Abstract][Full Text] [Related]
76. Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy. Zeng C; Zhai T; Chen J; Guo L; Huang B; Guo H; Liu G; Zhuang T; Liu W; Luo T; Wu Y; Peng G; Li D; Chen C Radiat Oncol; 2021 Jan; 16(1):8. PubMed ID: 33436018 [TBL] [Abstract][Full Text] [Related]
77. Consensus Clustering Analysis Based on Enhanced-CT Radiomic Features: Esophageal Squamous Cell Carcinoma patients' 3-Year Progression-Free Survival. Jia J; Liu Z; Wang F; Bai G Acad Radiol; 2024 Jul; 31(7):2807-2817. PubMed ID: 38199900 [TBL] [Abstract][Full Text] [Related]
78. Response Prediction Using Hu X; Zhou T; Ren J; Duan J; Wu H; Liu X; Mu Z; Liu N; Wei Y; Yuan S J Nucl Med; 2023 Apr; 64(4):625-631. PubMed ID: 36229183 [TBL] [Abstract][Full Text] [Related]
79. Reproducibility and location-stability of radiomic features derived from cone-beam computed tomography: a phantom study. He X; Chen Z; Gao Y; Wang W; You M Dentomaxillofac Radiol; 2023 Nov; 52(8):20230180. PubMed ID: 37664997 [TBL] [Abstract][Full Text] [Related]
80. Prognostic value of pre-therapeutic nutritional risk factors in elderly patients with locally advanced esophageal squamous cell carcinoma receiving definitive chemoradiotherapy or radiotherapy. Qiu J; Yang J; Yu Y; Wang Z; Lin H; Ke D; Zheng H; Li J; Yao Q BMC Cancer; 2023 Jun; 23(1):597. PubMed ID: 37380982 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]